In the SUSTAIN 6 trial, over 3,297 patients with type 2 diabetes with established chronic kidney disease and/or cardiovascular disease underwent randomization to semaglutide or placebo and were followed for 2 years resulting in a 26% risk reduction in the combined endpoint of rate of cardiovascular disease, nonfatal myocardial infarction, or nonfatal stroke [47]
Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish
Always remove air bubbles before injecting
Manufactured through controlled production workflows, each lot is handled under internal quality procedures designed to support consistency, documentation, and traceability
As an editorial team, we independently create content and determine coverage based on research, reporting and what we think TODAY.com readers would like to read about